Peptides identify the critical hotspots involved in the biological activation of the insulin receptor

被引:70
作者
Pillutla, RC
Hsiao, KC
Beasley, JR
Brandt, J
Ostergaard, S
Hansen, PH
Spetzler, JC
Danielsen, GM
Andersen, AS
Brissette, RE
Lennick, M
Fletcher, PW
Blume, AJ
Schäffer, L
Goldstein, NI [1 ]
机构
[1] DGI Technol, Dept Mol Biol, Edison, NJ 08818 USA
[2] DGI Technol, Dept Screening Technol, Edison, NJ 08818 USA
[3] DGI Technol, Dept Prot Technol, Edison, NJ 08818 USA
[4] Novo Nordisk AS, Dept Insulin Res, DK-2880 Bagsvaerd, Denmark
[5] Novo Nordisk AS, Dept Diabet Biol, DK-2880 Bagsvaerd, Denmark
关键词
D O I
10.1074/jbc.M202119200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We used phage display to generate surrogate peptides that define the hotspots involved in protein-protein interaction between insulin and the insulin receptor. All of the peptides competed for insulin binding and had affinity constants in the high nanomolar to low micromolar range. Based on competition studies, peptides were grouped into non-overlapping Sites 1, 2, or 3. Some Site 1 peptides were able to activate the tyrosine kinase activity of the insulin receptor and act as agonists in the insulin-dependent fat cell assay, suggesting that Site 1 marks the hotspot involved in insulin-induced activation of the insulin receptor. On the other hand, Site 2 and 3 peptides were found to act as antagonists in the phosphorylation and fat cell assays. These data show that a peptide display can be used to define the molecular architecture of a receptor and to identify the critical regions required for biological activity in a site-directed manner.
引用
收藏
页码:22590 / 22594
页数:5
相关论文
共 22 条
  • [1] Fusion of insulin receptor ectodomains to immunoglobulin constant domains reproduces high-affinity insulin binding in vitro
    Bass, J
    Kurose, T
    Pashmforoush, M
    Steiner, DF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) : 19367 - 19375
  • [2] Blume AJ, 2000, BIOPOLYMERS, V55, P347, DOI 10.1002/1097-0282(2000)55:4<347::AID-BIP1007>3.0.CO
  • [3] 2-J
  • [4] Unexpected frameshifts from gene to expressed protein in a phage-displayed peptide library
    Cárcamo, J
    Ravera, MW
    Brissette, R
    Dedova, O
    Beasley, JR
    Alam-Moghé, A
    Wan, CH
    Blume, A
    Mandecki, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) : 11146 - 11151
  • [5] Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine
    Cwirla, SE
    Balasubramanian, P
    Duffin, DJ
    Wagstrom, CR
    Gates, CM
    Singer, SC
    Davis, AM
    Tansik, RL
    Mattheakis, LC
    Boytos, CM
    Schatz, PJ
    Baccanari, DP
    Wrighton, NC
    Barrett, RW
    Dower, WJ
    [J]. SCIENCE, 1997, 276 (5319) : 1696 - 1699
  • [6] THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR - STRUCTURE, LIGAND-BINDING MECHANISM AND SIGNAL-TRANSDUCTION
    DEMEYTS, P
    WALLACH, B
    CHRISTOFFERSEN, CT
    URSO, B
    GRONSKOV, K
    LATUS, LJ
    YAKUSHIJI, F
    ILONDO, MM
    SHYMKO, RM
    [J]. HORMONE RESEARCH, 1994, 42 (4-5) : 152 - 169
  • [7] An evaluation of the cross-linking model for the interaction of insulin with its receptor
    Hammond, BJ
    Tikerpae, J
    Smith, GD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 272 (06): : E1136 - E1144
  • [8] Structural analysis of receptor tyrosine kinases
    Hubbard, SR
    [J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1999, 71 (3-4) : 343 - 358
  • [9] Expression and characterization of a 70-kDa fragment of the insulin receptor that binds insulin -: Minimizing ligand binding domain of the insulin receptor
    Kristensen, C
    Wiberg, FC
    Schäffer, L
    Andersen, AS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (28) : 17780 - 17786
  • [10] Conformational changes of the insulin receptor upon insulin binding and activation as monitored by fluorescence spectroscopy
    Lee, J
    Pilch, PF
    Shoelson, SE
    Scarlata, SF
    [J]. BIOCHEMISTRY, 1997, 36 (09) : 2701 - 2708